Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus

Neuropharmacology

Volumn 39, Issue 10, 2000, Pages 1823-1832

  Raap, Daní K ^a   Doncarlos, Lydia ^a   Garcia, Francisca ^a   Muma, Nancy A ^a   Wolf, William A ^b   Battaglia, George ^a   Van De Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ACTH; Antidepressants; G protein; Oxytocin; Serotonin; Signaling

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CORTICOSTERONE; CORTICOTROPIN; ESTROGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; OXYTOCIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ESTROGEN THERAPY; FEMALE; HORMONE RESPONSE; HYPOTHALAMUS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; ESTROGENS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HETEROTRIMERIC GTP-BINDING PROTEINS; HYPOTHALAMUS; OVARIECTOMY; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1;

EID: 0034045736     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00264-6     Document Type: Article

References (81)

1. 1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology. 14:1996;19-25.
2. Alves S.E., Lopez V., McEwen B.S., Weiland N.G. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proceedings of the National Academy of Sciences, USA. 95:1998;3281-3286.
3. Arpels J.C. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause - A hypothesis and review of supporting data. Journal of Reproductive Medicine. 41:1996;633-639.
4. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behavioral Brain Research. 73:1996;277-280.
5. Baischer W., Koinig G., Hartmann B., Huber J., Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology. 20:1995;553-559.
6. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor G protein coupling. Journal of Biological Chemistry. 272:1997;2223-2229.
7. Barr L.C., Goodman W.K., McDougle C.J., Delgado P.L., Heninger G.R., Charney D.S., Price L.H. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Archives of General Psychiatry. 51:1994;309-317.
8. 1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Clinical and Pharmacological Therapeutics. 63:1998;428-436.
9. 1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein α-subunits. Journal of Biological Chemistry. 267:1992;8200-8206.
10. 1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. Journal of Pharmacological and Experimental Therapeutics. 265:1993;7-15.
11. Bouvier C., Lagace G., Collu R. G protein modulation by estrogens. Molecular and Cellular Endocrinology. 79:1991;65-73.
12. Burgess L.H., Handa R.J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology. 131:1992;1261-1269.
13. 1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. Journal of Biological Chemistry. 270:1995;18691-18699.
14. Cone R.I., Davis G.S., Goy R.W. Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Research Bulletin. 7:1981;639-644.
15. Ellenbogen M.A., Young S.N., Dean P., Palmour R.M., Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology. 15:1996;465-474.
16. Fields T.A., Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochemical Journal. 321:1997;561-571.
17. Fink G., Sumner B.E.H., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cellular and Molecular Neurobiology. 16:1996;325-344.
18. Frankfurt M., Mckittrick C.R., Mendelson S.D., McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology. 59:1994;245-250.
19. 1A receptor subtype increases rat plasma ACTH concentration. European Journal of Pharmacology. 147:1988;431-439.
20. Goldberg R.J. Diagnostic dilemmas presented by patients with anxiety and depression. American Journal of Medicine. 98:1995;278-284.
21. Goldstein D.J., Wilson M.G., Thompson V.L., Potvin J.H., Rampey A.H.,Jr. and Fluoxetine Bulimia Nervosa Research Group, 1995. Long-term fluoxetine treatment of bulimia nervosa. British Journal of Psychiatry 166, 660-666.
22. Gonzalez M.I., Greengrass P., Russell M., Wilson C.A. Comparison of serotonin receptor numbers and activity in specific hypothalamic areas of sexually active and inactive female rats. Neuroendocrinology. 66:1997;384-392.
23. 1A receptors. Brain Research. 770:1997;10-17.
24. Halbreich U. Gonadal hormones and antihormones, serotonin and mood. Psychopharmacology Bulletin. 28:1990;291-295.
25. Handa R.J., Burgess L.H., Kerr J.E., O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Hormones and Behavior. 28:1994;464-476.
26. Handley S.L. 5-hydroxytryptamine pathways in anxiety and its treatment. Pharmacological Therapeutics. 66:1995;103-148.
27. Hrabovszky E., Kalló I., Hajszán T., Shughrue P.J., Merchenthaler I., Liposits Z. Expression of estrogen receptor-β messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. Endocrinology. 139:1998;2600-2604.
28. 1A agonist, 8-OH-DPAT, on lordosis behavior. Hormones and Behavior. 30:1996;145-152.
29. 1A receptor agonist action. Brain Research. 796:1998;299-302.
30. Jimerson D.C., Wolfe B.E., Metzger E.D., Finkelstein D.M., Cooper T.B., Levine J.M. Decreased serotonin function in bulimia nervosa. Archives of General Psychiatry. 54:1997;529-534.
31. Joffe R., Schuller D.R. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. Journal of Clinical Psychiatry. 54:1993;269-271.
32. 1A receptor in the acutely dissociated rat dorsal raphe neurons. Brain Research. 745:1997;283-292.
33. King T.S., Steger R.W., Morgan W.W. Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Neuroendocrinology. 42:1986;344-350.
34. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences, USA. 93:1996;5925-5930.
35. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. Journal of Neurobiology. 36:1998;357-378.
36. Lerer B., Gelfin Y., Gorfine M. Temperature and hormone responses of normal subjects to ipsapirone challenge: effect of fluoxetine treatment. Psychoneuroendocrinology. 22:1997;S166.
37. 1A receptor function in depression: effect of chronic amitriptyline treatment. Journal of Neural Transmission. 80:1990;157-161.
38. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology. 105:1991;415-420.
39. 1A agonist 8-OH-DPAT in male rats. Brain Research. 630:1993;148-156.
40. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biological Psychiatry. 36:1994;300-308.
41. 1A agonist. Journal of Pharmacological and Experimental Therapeutics. 279:1996;1035-1042.
42. 1A receptors in the rat brain: lack of effect by repeated injections of fluoxetine. Brain Research. 769:1997;141-151.
43. 1A receptors. Journal of Pharmacological and Experimental Therapeutics. 282:1997;1581-1590.
44. Li X., Schwartz P.E., Rissman E.F. Distribution of estrogen receptor-β-like immunoreactivity in rat forebrain. Neuroendocrinology. 66:1997;63-67.
45. Lowry O.H., Rosebrough W.Y., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
46. 1A receptors and plasma corticosterone levels. General Pharmacology. 27:1996;355-361.
47. Menkes D.B., Coates D.C., Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome. Journal of Affective Disorders. 32:1994;37-44.
48. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. Federation of European Biochemical Societies Letters. 392:1996;49-53.
49. Mize A.L., Alper R.H. Estradiol attenuates Gi coupled neurotransmitter receptor function in the female rat brain. Society of Neuroscience Abstracts. 25:1999;437.
50. o in neuroblastoma X glioma hybrid cells: independent regulation during cyclic AMP-induced differentiation. Journal of Neurochemistry. 55:1990;1890-1898.
51. 1A receptor expressed in sf9 insect cells. Biochemistry. 34:1995;11954-11962.
52. 1A receptors activate a potassium conductance in rat ventromedial hypothalamic neurones. European Journal of Pharmacology. 210:1992;209-212.
53. 1A potassium current. Journal of Neurophysiology. 74:1995;2189-2193.
54. 1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat. Neuroendocrinology. 56:1992;797-802.
55. Pecins-Thompson M., Brown N.A., Kohama S.G., Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in Rhesus macaques. Journal of Neuroscience. 16:1996;7021-7029.
56. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Molecular Brain Research. 53:1998;120-129.
57. 1A receptors on dorsal raphe neurones of the adult rat. Journal of Physiology. 469:1993;387-405.
58. Petersen D.N., Tkalcevic G.T., Koza-Taylor P.H., Turi T.G., Brown T.A. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology. 139:1998;1082-1092.
59. Petrov T., Krukoff T.L., Jhamandas J.H. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell and Tissue Research. 277:1994;289-295.
60. i proteins. Journal of Pharmacological and Experimental Therapeutics. 288:1999;98-106.
61. i/o/z proteins. Journal of Pharmacological and Experimental Therapeutics. 288:1999;561-567.
62. Ramirez V.D., Zheng J. Membrane sex-steroid receptors in the brain. Frontiers in Neuroendocrinology. 17:1996;402-439.
63. 2+ channels in rat ventromedial hypothalamic neurons. Neuropharmacology. 35:1996;1093-1100.
64. 1A receptor sensitivity. Psychopharmacology. 132:1997;296-302.
65. Schneider L.S., Small G.W., Hamilton S.H., Bysteritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine collaborative Study Group. American Journal of Geriatric Psychiatry. 5:1997;97-106.
66. 1A agonist 8-OH-DPAT. Neuroscience Abstract. 24:1998;539.18.
67. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids. 61:1996;678-681.
68. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. Journal of Comparative Neurology. 388:1997;507-525.
69. Simonian S.X., Herbison A.E. Differential expression of estrogen receptor α and β immunoreactivity by oxytocin neurons of rat paraventricular nucleus. Journal of Neuroendocrinology. 9:1997;803-806.
70. Steel R.G.D., Torrie J.H. Principles and Procedures of Statistics with Special Reference to the Biological Sciences. 1960;McGraw-Hill, New York.
71. Steiner M. Female-specific mood disorders. Clinical Obstetrics and Gynecology. 35:1992;599-611.
72. Sundblad C., Hedberg M.A., Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology. 9:1993;133-145.
73. Ulrich U., Nowara I., Rossmanith W.G. Serotoninergic control of gonadotrophin and prolactin secretion in women. Clinical Endocrinology. 41:1994;779-785.
74. 1A agonist in the VMN. Brain Research. 637:1994;173-180.
75. 1A agonist and potential anxiolytic drug alnespirone (S-20499). Pharmacology and Biochemistry of Behavior. 61:1998;677-683.
76. 1A receptor-mediated increase in oxytocin and ACTH secretion. Neuroscience Abstracts. 24:1998;539.17.
77. Vicentic A., Li Q., Battaglia G., Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH, and corticosterone, but not prolactin secretion. European Journal of Pharmacology. 346:1998;261-266.
78. Wikander I., Sundblad C., Andersch B., Dagnell I., Zylberstein D., Bengtsson F., Eriksson E. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? Journal of Clinical Psychopharmacology. 18:1998;390-398.
79. 2 receptor subtype mRNAs in rat brain. Journal of Comparative Neurology. 351:1995;357-373.
80. Yonkers K.A. The association between premenstrual dysphoric disorder and other mood disorders. Journal of Clinical Psychiatry. 58(Suppl. 15):1997;19-25.
81. Yonkers K.A. Antidepressants in the treatment of premenstrual dysphoric disorder. Journal of Clinical Psychiatry. 58(Suppl. 14):1997;4-13.